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ABSTRACT
Objective: To evaluate health professionals’
agreement with components of published diagnostic
criteria for fetal alcohol spectrum disorders (FASD) in
order to guide the development of standard diagnostic
guidelines for Australia.
Design: A modified Delphi process was used to
assess agreement among health professionals with
expertise or experience in FASD screening or
diagnosis. An online survey, which included 36 Likert
statements on diagnostic methods, was administered
over two survey rounds. For fetal alcohol syndrome
(FAS), health professionals were presented with
concepts from the Institute of Medicine (IOM),
University of Washington (UW), Centers for Disease
Control (CDC), revised IOM and Canadian diagnostic
criteria. For partial FAS (PFAS), alcohol-related
neurodevelopmental disorder (ARND), and alcohol-
related birth defects (ARBD), concepts based on the
IOM and the Canadian diagnostic criteria were
compared.
Setting/participants: 130 Australian and 9
international health professionals.
Results: Of 139 health professionals invited to
complete the survey, 103 (74.1%) responded, and
74 (53.2%) completed one or more questions on
diagnostic criteria. We found consensus agreement
among participants on the diagnostic criteria for FAS,
with the UW criteria most commonly endorsed when
compared with all other published criteria for FAS.
When health professionals were presented with
concepts based on the Canadian and IOM diagnostic
criteria, we found consensus agreement but no clear
preference for either the Canadian or IOM criteria for
the diagnosis of PFAS, and no consensus agreement
on diagnostic criteria for ARND. We also found no
consensus on the IOM diagnostic criteria for ARBD.
Conclusions: Participants indicated clear support for
use of the UW diagnostic criteria for FAS in Australia.
These findings should be used to develop guidelines to
facilitate improved awareness of, and address identified
gaps in the infrastructure for, FASD diagnosis in
Australia.
INTRODUCTION
Prenatal exposure to alcohol is associated with
a wide range of impacts,1 including intellectual
disability, behavioural disorders, growth restric-
tion, birth defects and dysmorphic facial
ARTICLE SUMMARY
Article focus
▪ There are no recommended standard criteria for
diagnosis of fetal alcohol spectrum disorder
(FASD) in Australia and there is a little informa-
tion on clinician practice and preference to guide
the development of guidelines for diagnosis.
▪ We aimed to evaluate health professionals’ agree-
ment with components of published diagnostic
criteria for FASD in order to guide the develop-
ment of standard diagnostic guidelines for
Australia.
Key messages
▪ There is a clear consensus among health profes-
sionals on the diagnostic criteria for fetal alcohol
syndrome (FAS) in Australia.
▪ National guidelines for FASD diagnosis in
Australia should incorporate components of the
University of Washington diagnostic criteria.
Strengths and limitations of this study
▪ Our findings provide evidence that is relevant to
the development of guidelines for the diagnosis
of FASD in Australia based on consultation with
health professionals.
▪ Evaluation of diagnostic criteria for partial FAS
(PFAS), alcohol-related neurodevelopmental dis-
order (ARND), and alcohol-related birth defects
only compared concepts from the original (Institute
of Medicine) and the most recent (Canadian) pub-
lished guidelines. Based on our finding of a clear
preference for the University of Washington criteria
for FAS, further work is required to identify whether
there is consensus agreement for University of
Washington criteria for PFAS and ARND.
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features.2 Among the range of diagnostic outcomes that
may be identiﬁed, fetal alcohol syndrome (FAS) is most
easily recognised.3 4 However, the spectrum of disorders
more frequently includes neurodevelopmental disorders
that are not accompanied by the characteristic FAS-facial
anomalies and are more difﬁcult to diagnose.4
Information on the diagnosis of fetal alcohol spectrum
disorders (FASD) in Australia is limited, with no routine
national surveillance for FASD, no recommended
national standards for diagnosis and evidence of incon-
sistent and inadequate5–7 diagnostic practices. In a large
survey of paediatricians in Western Australia approxi-
mately 20% were able to identify the diagnostic features
of FAS, despite almost 50% reporting that they had diag-
nosed the condition.8 The absence of accepted guide-
lines for referral and diagnosis has likely contributed to
poor case ascertainment, misdiagnosis, and a conse-
quent lack of access to health, education and social
services.9
Variation in the diagnosis of FASD between practi-
tioners can be attributed to the absence of well-deﬁned
criteria for assessment,1 poor awareness of diagnostic cri-
teria and the inconsistent application of guidelines for
diagnosis of FASD.2 4 9–11 Diagnostic guidelines are not
always implemented consistently12 and there is substan-
tial overlap between guidelines used internationally. The
most recently published diagnostic guidelines2 sought to
provide an agreed, evidence-based diagnostic standard
for Canada. The Canadian guidelines harmonise the
two main approaches to diagnosis, adopting terminology
from the Institute of Medicine (IOM) diagnostic cri-
teria4 and the University of Washington (UW) FASD
4-Digit Diagnostic Code10 approach to diagnostic assess-
ment and measurement.2
A standardised national approach to the diagnosis of
FASD would improve diagnostic capacity and consistency
in Australia; however, there is little empirical informa-
tion available to compare the performance of published
guidelines and inform the development of standard
guidelines. There are no internationally agreed stan-
dards for FASD diagnosis and a survey of health profes-
sionals demonstrated that most were unsure about
whether any of the existing diagnostic guidelines should
be adopted in Australia.13 Consistent with the recog-
nised need to evaluate guidelines when they are
adopted in different contexts14 15 we aimed to evaluate
health professionals’ agreement with components of
published diagnostic criteria for FASD in order to guide




A modiﬁed Delphi process16 with two survey rounds was
used to assess health professionals’ agreement with diag-
nostic criteria for FASD derived from existing diagnostic
guidelines.2 4 9–11 Agreement with different methods of
service delivery, including several concepts included in
the Western Australian FASD model of care17 were also
explored. The round 1 questionnaire included: 9 state-
ments which evaluated agreement with general diagnos-
tic processes; 21 statements which evaluated agreement
with general and speciﬁc components of the IOM,4
UW,10 Centers for Disease Control (CDC),9 revised
IOM11 and Canadian2 diagnostic criteria for FAS; and
six statements which evaluated agreement with diagnos-
tic criteria for partial FAS (PFAS), alcohol-related neuro-
developmental disorder (ARND) and alcohol-related
birth defects (ARBD) based on a comparison of con-
cepts from the original IOM diagnostic criteria4 and the
more recently developed Canadian guidelines.2
Participants were asked to rate their agreement with
each statement on a ﬁve-point Likert scale which ranged
from ‘strongly agree’ to ‘strongly disagree’ or to select
‘no comment’ if a statement was outside their area of
expertise. These statements on diagnosis were adminis-
tered as part of a larger survey on the screening and
diagnosis of FASD in Australia.
Panel recruitment
As the Delphi study method requires participants with
expertise relevant to the study objective,18–20 a large
panel of health professionals with expertise or experi-
ence in the screening and diagnosis of FASD was
recruited. The ﬁrst round of the survey started with 139
panel members: 40 were recruited having reported a
child with FAS to the Australian Paediatric Surveillance
Unit (APSU) in a previous study,5 68 were identiﬁed by
study investigators as having experience or expertise in
FASD screening or diagnosis (including nine inter-
national experts) and 31 responded to calls to health-
professional organisations for individuals with relevant
experience or expertise.
Questionnaire administration
The password-protected questionnaire was administered
online from a secure web server. A personalised email
was sent to all panel members inviting them to complete
the ﬁrst round within 14 days. Two email reminders
about questionnaire completion were sent prior to the
round deadline. Non-responders for whom we had
contact details were contacted by telephone and given
another 8 days to respond. Participants who did not
complete the round 1 questionnaire were excluded from
round 2. Due to the potential for feedback about ﬁnd-
ings from round 1 to inﬂuence participation in round 2,
individuals who ﬁrst responded to the statements on
diagnostic criteria in round 2 were excluded from this
analysis.
Questionnaire revision
The following criteria were used to determine whether
consensus agreement was reached on the statements
included in round 1 and whether they required reassess-
ment in round 2 or were rejected:
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1. if at least 70% of participants agreed or strongly
agreed with a statement, it was considered endorsed.
This level of consensus was decided a priori.
Endorsed statements were omitted from the round 2
questionnaire if not closely related to other state-
ments included in round 2;
2. if 60–69% of participants agreed or strongly agreed
with a statement, it was re-administered in round 2 in
its original or in a modiﬁed form;
3. if fewer than 60% of participants agreed or strongly
agreed with a statement, the statement was rejected
or modiﬁed.
In the round 2 questionnaire we provided feedback of
group and individual agreement with statements in
round 1.
Analysis
Descriptive statistics were generated for each statement,
including response frequencies and dispersion (interquar-
tile deviation). Achievement of consensus was evaluated
based on all valid responses. Associations between state-
ment ratings and individual characteristics of participants
(occupation, experience in FASD diagnosis, completion of
training on FASD diagnosis and completeness of
response) were explored using the χ test or Fisher’s exact
test.21 The Wilcoxon-signed rank test was used to compare
the level of agreement between IOM and Canadian diag-
nostic criteria for PFAS and ARND. All analyses were evalu-
ated using two-tailed test statistics. Approval for this study
was granted by The University of Western Australia
Human Research Ethics Committee and the Western
Australian Aboriginal Health Information and Ethics
Committee.
RESULTS
Although 103 participants (74.1%) responded to the
survey, only 74 (53.2%) answered one or more of the 27
round 1 questionnaire statements on diagnostic criteria.
Sociodemographic characteristics for these 74 partici-
pants are summarised in table 1.
Diagnostic services
Most participants agreed (responded ‘agree’ or ‘strongly
agree’) that a medical specialist (eg, paediatrician or
clinical geneticist) should conﬁrm the diagnosis of
FASD (78.6% after round 2) and exclude alternative
diagnoses (89.5% after round 2). Although some partici-
pants commented that diagnosis by general practitioners
may be appropriate in rural and remote areas, there was
not consensus agreement on the involvement of general
practitioners in diagnosis in rural and remote areas
(table 2). There was consensus agreement on the need
for multidisciplinary assessment, that multidisciplinary
assessment clinics should be available in major cities and
that assessment teams should visit regional centres to
support workforce training and development.
Paediatricians were less likely than other health profes-
sionals to agree on the need for multidisciplinary assess-
ment and scheduled visits to regional centres (table 2).
Diagnostic criteria for FAS
There was clear consensus agreement on general and
speciﬁc statements regarding diagnostic criteria for FAS
Table 1 Participant characteristics by occupational group
Characteristic n Paediatrician (%) Other* (%) p Value†
Country of residence 0.12‡
Australia 67 49.3 50.7
Other 7 14.3 85.7
Sex <0.001
Female 54 33.3 66.7
Male 20 80.8 20.0
Experience in diagnosis <0.001
No 37 21.6 78.4
Yes 35 71.4 28.6
Contributed§ to diagnosis 0.003
No 15 13.3 86.7
Yes 57 54.4 45.6
Training in diagnosis 0.82
No 49 44.9 55.1
Yes 23 47.8 52.2
Practice in rural or remote area 0.43
No 40 50.0 50.0
Yes 32 40.6 59.4
*Other occupations include: allied health professional (psychologist, occupational therapist, physiotherapist, social worker and speech
pathologist), midwife/nurse, other medical practitioner, health researcher and aboriginal health/community worker.
†χ test for independence by occupation (paediatrician vs other health professionals).
‡Fisher’s exact test.
§Conducts relevant assessments but does not make the final diagnosis.
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that were consistent with the UW guidelines (tables 3
and 4). Most participants (75.5% overall) agreed with
components of the UW criteria for central nervous
system (CNS) abnormality (statement 11 table 4). There
was a substantial difference in agreement between the
UW and the IOM criteria (44.9% overall, statement 10
table 4) for CNS abnormality (z=‐2.93, p=0.003);
however, there was no strong evidence of difference
between the Canadian (60.0% overall, statement 12
table 4) and the IOM criteria (z=‐1.42, p=0.16). Fewer
than half the paediatricians (42.9%) agreed with the
Canadian criteria for CNS abnormality compared with
81.8% of other health professionals (statement 12
table 4).
Diagnostic criteria for PFAS, ARND and ARBD
There was consensus agreement on both deﬁnitions of
PFAS, with no evidence of difference in agreement
between the IOM (70.6% overall, statement 1, table 5)
and Canadian (74.0% overall, statement 2, table 5) cri-
teria (z=‐0.50, p=0.62). There was no consensus agree-
ment on the diagnostic criteria for ARND, with no






Statement n Paediatrician Other
p
Value* n Paediatrician Other
p
Value*
1. Evaluation by a general or subspecialist
paediatrician or clinical geneticist is required
to confirm the diagnosis of a FASD
67 77.4 (1) 72.2 (2) 0.63 56 79.2 (0) 78.1 (1) 0.93
2. Evaluation by a general or subspecialist
paediatrician or clinical geneticist is required
to exclude alternative diagnoses
71 73.5 (2) 89.2 (1) 0.09 57 87.5 (1) 90.9 (1) 0.69†
3. With appropriate FASD-specific training,
general practitioners can confirm the diagnosis
of a FASD
69 46.9 (2) 43.2 (2) 0.76 – – – –
4. With appropriate FASD-specific training,
general practitioners can exclude alternative
diagnoses
67 25.8 (2) 36.1 (2) 0.36 – – – –
5. With appropriate FASD-specific training,
general practitioners in rural and remote
settings can confirm the diagnosis of a FASD‡
– – – – 57 58.3 (2) 63.6 (2) 0.69
6. With appropriate FASD-specific training,
general practitioners in rural and remote
settings can exclude alternative diagnoses‡
– – – – 57 37.5 (2) 48.5 (2) 0.41
7. Diagnosis of FASD should involve
multidisciplinary assessment by FASD
accredited paediatricians and other health
professionals
(eg, social worker, psychologist, speech
pathologist, occupational therapist,
physiotherapist and nurse practitioner)
72 70.6 (2) 89.5 (1) 0.04 – – – –
8. A multidisciplinary FASD assessment clinic
should be available in major cities
73 78.8 (1) 95.0 (0) 0.07† – – – –
9. Scheduled visits by FASD assessment teams
to regional centres should be used to perform
FASD screening and diagnosis
70 54.5 (1) 94.6 (1) <0.001 – – – –
10. Scheduled visits by FASD assessment teams
to regional centres should be used to support
workforce training and development for FASD
screening and diagnosis
71 78.8 (0) 100 (0) 0.003 – – – –
11. Telehealth should be used by FASD
assessment teams to support FASD screening
and diagnosis
70 68.8 (2) 86.8 (1) 0.07 – – – –
*χ test for independence by occupation (paediatrician vs other occupation).
†Fisher’s exact test.
‡New statements added to the round 2 questionnaire.
Statements that reached 70% agreement (‘agree’ or ‘strongly agree’) for the total sample are presented in italic.
FASD, fetal alcohol spectrum disorders; IQD, interquartile deviation.
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evidence of difference in agreement between the IOM
(59.5% overall, statement 3, table 5) and Canadian
(57.5% overall, statement 4, table 5) criteria (z=0.31,
p=0.75). No consensus agreement was reached on the
IOM deﬁnition of ARBD (64.4% overall, statement 6,
table 5), and 90.4% of participants agreed that better
evidence is required on the association between alcohol
and birth defects before the diagnostic category is clinic-
ally useful (table 5).
Response completeness and survey non-response
Only 36 of the 74 participants (48.6%) completed 22 or
more of the 27 diagnostic criteria statements. Most parti-
cipants who completed 21 or fewer of the 27 diagnostic
criteria statements indicated through use of the ‘no
comment’ response that the omitted statements were
outside their area of expertise. Completion of 21 or
fewer diagnostic criteria statements was more frequent
among other health professionals (65.8%), participants
who had no experience in diagnosis (67.6%) and parti-
cipants who had not completed training on diagnosis
(86.1%) than among paediatricians (34.2%, p=0.04),
participants who had experience in diagnosis (31.4%,
p=0.002) and participants who had completed training
on diagnosis (13.9%, p=0.001), respectively.
Among the 74 participants, those who completed 21
or fewer diagnostic criteria statements were less likely to
agree with the general deﬁnition of the four features of
FAS in round 1 (44.4%, statement 1 table 3) compared
with participants who completed 22 or more statements
(75%, p=0.01). Compared with participants who com-
pleted 22 or more statements, participants who com-
pleted 21 or fewer statements were also more likely to
agree with the IOM criteria for facial anomalies (73.7%,
statement 3 table 3 vs 45.7%, p=0.045), IOM criteria for
CNS abnormality (71.4%, statement 10 table 3 vs 34.3%,
p=0.02) and general criteria for growth deﬁcit (state-
ments 5, 6 and 7 table 3, all p<0.02). The exclusion of
individuals who responded to the statements on diagnos-
tic criteria for the ﬁrst time in the round 2 questionnaire
did not inﬂuence the achievement of consensus agree-
ment for any statement or alter the conclusions drawn
from this analysis (data not shown).
Although there was no evidence of an association
between occupation and completion of any question-
naire statement on diagnostic criteria either among the
139 panel members (p=0.2) or among the 103 panel
members who responded to the survey (p=0.46); non-
response to the survey overall (36/139 panel members)
was more frequent among paediatricians (36.6%) than
among other health professionals (14.7%, p=0.003).
Among the 103 survey participants, paediatricians were
also more likely to complete 22 or more of the 27 diag-
nostic criteria statements (46.7%) than other health pro-
fessionals (25.9%, p=0.03).
DISCUSSION
We found consensus agreement among participants on
the diagnostic criteria for FAS. Diagnostic criteria for
FAS are the most well-established22 and all published
guidelines2 4 9–11 include similar and necessary ele-
ments: characteristic facial dysmorphology, growth
impairment and CNS abnormality. However, there are
important differences between guidelines. Participants
indicated a clear preference for all main components of
the case-deﬁned UW criteria, including a substantially
greater level of agreement with the UW criteria for CNS
abnormality than with the IOM criteria.
The endorsed UW deﬁnition of CNS abnormalities
includes either structural/neurological criteria or func-
tional criteria that are each alone sufﬁcient to deﬁne






Statement n Paediatrician Other
p
Value* n Paediatrician Other
p
Value*
1. A diagnosis of FAS should only be made in the
presence of all four of the following: confirmed
or unknown prenatal alcohol exposure, all three
characteristic FAS facial anomalies, growth
deficit and CNS abnormality†
63 56.3 (2) 67.7 (3) 0.35 53 84.0 (1) 78.6 (1) 0.73
2. A confirmed absence of prenatal alcohol
exposure (in the presence of all other required
FAS findings) should rule out a diagnosis of
FAS and be recorded under a different
diagnostic category
69 69.7 (2) 72.2 (2) 0.82 – – – –
*χ test for independence by occupation (paediatrician vs other occupation).
†Statement wording used in round 2. Round 1 statement list included ‘characteristic FAS facial anomalies, growth deficit, CNS abnormalities
and confirmed or unknown prenatal alcohol exposure.’
Statements that reached 70% agreement (‘agree’ or ‘strongly agree’) for the total sample are presented in italic.
CNS, central nervous system; FAS, fetal alcohol syndrome; IQD, interquartile deviation
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CNS abnormality. This may allow an FAS diagnosis to be
made earlier than with use of the Canadian guidelines
which, in the absence of structural CNS defects, require
deﬁcit in at least three domains of function and thus
have greater dependence on neurobehavioural assess-
ments whose use may be limited by age.2 The require-
ment for evidence of structural/neurological or
substantial functional abnormality is common to both
the UW and CDC guidelines.9 However, the use of the
third percentile criterion for cranial size and functional
performance indicators distinguishes the UW and CDC
criteria, and results in a more conservative UW deﬁn-
ition of abnormality.
We found no signiﬁcant difference in agreement
between the IOM and Canadian criteria for the diagno-
sis of PFAS, ARND or criteria for CNS abnormality. Both




Statement n Paediatrician Other Statement
Facial anomalies
1. All three of the following characteristic FAS facial anomalies: (short-palpebral
fissures, thin-upper lip and smooth philtrum)
54 71.4 (3) 76.9 (1) 0.65
2. Two or more of the following characteristic FAS facial anomalies: (short-palpebral
fissures, thin-upper lip and smooth philtrum)
52 50.0 (2) 62.5 (2) 0.37
3. Evidence of a characteristic pattern of FAS facial anomalies that includes
features such as short-palpebral fissures and abnormalities in the premaxillary
zone (eg, flat-upper lip and flattened philtrum)
54 44.8 (2) 68.0 (2) 0.09
Growth deficit
4. Prenatal or postnatal growth deficit in height or weight at or below the 10th
percentile
50 72.4 (1) 90.5 (1) 0.16
5. Disproportionately low weight-to-height ratio at or below 10th percentile 45 48.1 (1) 66.7 (1) 0.22
6. Disproportional low weight to height 46 42.9 (2) 61.1 (2) 0.23
7. Low-birth weight for gestational age 50 53.3 (1) 60.0 (1) 0.64
8. Decelerating weight over time not due to nutrition 49 42.9 (2) 66.7 (2) 0.10
CNS abnormalities—general
9. At least one structural CNS abnormality (including decreased cranial size), 45 60.0 (1) 50.0 (2) 0.50
10. At least one of the following CNS abnormalities: structural (abnormal-brain
structure, including decreased cranial size) or neurological (hard or soft
neurological signs)
49 37.0 (2) 54.5 (1) 0.22
11. At least one of the following CNS abnormalities:
structural (abnormal-brain structure, including decreased cranial size) or
neurological (hard or soft neurological signs) or functional (global cognitive or
intellectual deficits representing multiple domains of deficit (including significant
developmental delay in young children) or deficits in three or more specific
functional domains (eg, developmental milestones, cognition, memory, executive
functioning, attention, hyperactivity, social, communication and language, motor
and sensory))
49 76.9 (1) 73.9 (1) 0.81
12. Three or more of the following CNS abnormalities: structural (abnormal-brain
structure, including decreased cranial size), neurological (hard or soft
neurological signs), cognition, communication, academic achievement, memory,
executive functioning and abstract reasoning, attention deficit or hyperactivity,
adaptive behaviour, social skills and social communication
50 42.9 (2) 81.8 (1) 0.004
CNS abnormalities—specific
13. Decreased-cranial size at or below the third percentile 50 90.9 (1) 82.4 (1) 0.40
14. Decreased-cranial size at or below the 10th percentile 47 25.8 (2) 43.8 (2) 0.22
15. Global-functional performance (cognitive or intellectual) below the third percentile 52 78.8 (1) 78.9 (1) 1.00
16. Performance for specific-functional domains below the third percentile 50 77.4 (0) 89.5 (1) 0.45
17. Performance for specific-functional domains below the 16th percentile 46 17.9 (1) 44.4 (2) 0.052
18. Clinical judgement of functional impairment or deficit in domains where
standardised measurements are not available
53 62.5 (1) 52.4 (2) 0.47
19. Clinical judgement of functional impairment or deficit based on clinical
assessment
56 42.4 (2) 47.8 (2) 0.69
*χ test for independence by occupation (paediatrician vs other occupation).
Statements that reached 70% agreement (‘agree’ or ‘strongly agree’) for the total sample are presented in italic.
CNS, central nervous system; FAS, fetal alcohol syndrome; IQD, interquartile deviation
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Table 5 Comparison of agreement with statements about diagnostic criteria for PFAS, ARND and ARBD between





Statement n paediatrician other
p
Value* n paediatrician other
p
Value*
Diagnostic criteria for partial fetal alcohol syndrome
(PFAS)
1. Confirmed prenatal alcohol exposure, and
evidence of some components of the pattern of
characteristic FAS facial anomalies, and either:
growth deficit, or structural or neurological CNS
abnormality, or evidence of multiple behavioural
or cognitive abnormalities that are inconsistent
with developmental level (eg, learning, academic
achievement, poor impulse control, social skills,
receptive and expressive language, abstract
reasoning, attention, memory or judgement)
50 76.0 (1) 64.0 (3) 0.35 51 72.7 (1) 69.0 (2) 0.77
2. Confirmed prenatal alcohol exposure, and two of
the three characteristic FAS facial anomalies and
CNS abnormality in three of the following areas
(hard and soft neurological signs, brain structure,
cognition, communication, academic
achievement, memory, executive functioning and
abstract reasoning, attention deficit or
hyperactivity, adaptive behaviour, social skills,
social communication)
47 70.8 (1) 78.3 (1) 0.56 50 66.7 (2) 79.3 (0) 0.32
Diagnostic criteria for alcohol-related
neurodevelopmental disorder (ARND)
3. Confirmed prenatal alcohol exposure, and
evidence of CNS abnormality (decreased cranial
size, abnormal brain structure or neurological
hard or soft signs, including fine motor skills,
neurosensory hearing loss and co-ordination), or
evidence of multiple behavioural or cognitive
abnormalities that are inconsistent with
developmental level (eg, learning, academic
achievement, poor impulse control, social skills,
receptive and expressive language, abstract
reasoning, attention, memory or judgement)
43 77.3 (0) 66.7 (3) 0.44 42 57.9 (2) 60.9 (2) 0.85
4. Confirmed prenatal alcohol exposure, and CNS
abnormality in three of the following areas (hard
and soft neurologic signs, brain structure,
cognition, communication, academic
achievement, memory, executive functioning and
abstract reasoning, attention deficit or
hyperactivity, adaptive behaviour, social skills,
social communication)
42 69.6 (1) 63.2 (2) 0.66 40 52.6 (2) 61.9 (2) 0.55
Diagnostic criteria for alcohol-related birth defects
(ARBD)
5. Confirmed prenatal alcohol exposure, and
identification of alcohol-related birth defects on
clinical examination (including cardiac, skeletal,
renal, ocular, auditory or other malformations,
including facial anomalies)
46 78.3 (0) 60.9 (2) 0.20 42 23.8 (2) 38.1 (2) 0.32
6. Confirmed significant prenatal alcohol exposure,
and identification of alcohol-related birth defects
on clinical examination (including cardiac,
skeletal, renal, ocular, auditory or other
malformations, including facial anomalies)†
– – – – 45 63.6 (1) 65.2 (2) 0.91
Continued
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statements describing the IOM and Canadian diagnostic
criteria for PFAS reached consensus agreement despite
considerable differences between the criteria, including
that, unlike the IOM criteria, the Canadian criteria
require CNS dysfunction to be formally established.2
Lack of consensus agreement with either the Canadian
or IOM diagnostic criteria for FASD other than FAS is
consistent with more limited evidence on the aetio-
logical role of alcohol for these diagnoses,4 11 23 vari-
ation in the deﬁnition of these conditions among
diagnostic guidelines, limited information on the validity
and comparative performance of different diagnostic
methods, and exclusion of the diagnostic category
ARBD from three of the four most recently published
diagnostic guidelines.2 9 10
The lack of a clear preference for either the Canadian
or IOM diagnostic criteria for PFAS and ARND may also
be linked to the limited use and visibility of diagnostic
categories other than FAS in Australia.6 This could both
result from, and reinforce, uncertainty about the validity
of these diagnostic categories. Although the Canadian
and UW diagnostic criteria share many similarities, there
are some differences between these approaches. Further
exploration of agreement with the UW diagnostic cri-
teria for PFAS and ARND is needed to distinguish a lack
of support for the diagnostic category of ARND and a
lack of clear preference for diagnostic criteria for PFAS
from the speciﬁc and limited diagnostic criteria evalu-
ated in this survey. However, our ﬁnding of substantially
greater agreement with the UW deﬁnition of compo-
nents of the diagnostic criteria for FAS suggests
that there is strongest support for the UW approach to
deﬁning abnormalities, which also form the basis of the
UW diagnostic criteria for PFAS and ARND (static
encephalopathy alcohol exposed and neurobehavioural
disorder-alcohol exposed).
Consistent with more recent guidelines for the diagnosis
of FASD,2 9–11 a multidisciplinary approach to diagnosis
was supported, particularly among health professionals
other than paediatricians. The observed difference in
agreement among paediatricians and other health
professionals may reﬂect the difﬁculty in accessing multi-
disciplinary assessment services outside major metropol-
itan centres. Although participants were more likely to
agree that general practitioners in rural or remote settings
could conﬁrm a diagnosis of FASD compared with all
general practitioners, there was only limited support for
general practitioners assuming a key role in diagnosis.
Comments from some participants indicated that the lack
of support for the role of general practitioners in diagnosis
may be associated with the perceived need for speciﬁc
expertise in FASD diagnosis, a lack of time to complete the
diagnostic process in general practice, and the perceived
need for a specialist multidisciplinary diagnostic team.
Participants indicated most agreement with service provi-
sion strategies that help to build local diagnostic and inter-
vention capacity. A similar strategy is advocated in the
Canadian guidelines to address service provision in
remote communities by establishing regionally based diag-
nostic teams.2
Limitations of this study include its exploratory design,
the inability of the survey to represent published diagnos-
tic criteria within their full context, and the failure to
assess agreement with all published diagnostic criteria for
PFAS and ARND. Despite recruiting 139 individuals
known to have experience or expertise in screening or
diagnosis of FASD and a high response (74.1%), only
74 participants answered one or more of the 27 questions
on diagnostic criteria, and only 36 answered 22 or more
questions. However, due to the recruitment of panel
members based on experience or expertise on screening
or diagnosis and the examination of both screening and
diagnosis in the questionnaire, we did not anticipate that
all panel members would respond to the statements on
diagnostic criteria. We found that completeness of
response to the statements on diagnostic criteria was
related to training and experience in FASD diagnosis,
and likely reﬂects the limited familiarity with diagnostic
guidelines among Australian health professionals,13 and
the limited diagnostic capacity for FASD in Australia.
In conclusion, we found consensus agreement on the






Statement n paediatrician other
p
Value* n paediatrician other
p
Value*
7. Alcohol-related birth defects is not sufficiently
well defined to be a useful diagnostic category
43 59.1 (1) 52.4 (2) 0.66 – – – –
8. Better evidence of the association between
alcohol and particular birth defects is required for
ARBD to be a clinically useful diagnostic
category†
– – – – 52 100 (1) 82.1 (0) 0.054
*χ test for independence by occupation (paediatrician vs other occupation).
†New statements added to the round 2 questionnaire.
Statements that reached 70% agreement (‘agree’ or ‘strongly agree’) for the total sample are presented in italic.
CNS, central nervous system; FAS, fetal alcohol syndrome; IQD, interquartile deviation.
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differences between the perceptions of paediatricians
and other health professionals. Our ﬁndings indicate
strong support for the UW approach to deﬁning abnor-
malities which fulﬁls key best practice criteria,24 and
these data provide valuable consensus-based evidence
for guideline development that should be incorporated
in formal guideline development processes for FASD
diagnosis in Australia. The development of standard-
national guidelines for diagnosis can facilitate improved
awareness of diagnostic criteria, the use of consistent
diagnostic processes, and enable evaluation of the effect-
iveness of the prevention, detection and treatment of
these disorders in Australia.
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